Sue O'Leary | Executive Vice President, Evidence and Access
Prime Global

Sue is no stranger to the challenges of market access! Having spent the first few years of her career as a UK hospital pharmacist, managing formularies; she understands only too well the need to target limited resource and optimise new drug use.  She has never lost this grounding in the realities of healthcare systems and spent 15 years in the Global team at AstraZeneca, helping to shape new organisational initiatives, as HTAs were an emerging concept, and global to local activities became a key driver of a successful brand launch Sue now heads up the Evidence and Access Team at Prime, with a leadership team spanning US and Europe, supporting clients across the life-cycle, to make sure that evidence is optimal, not just for launch but beyond. The team comprises a mix of skilled health economists, medical writers and market access strategists who collectively will make sure global dossiers and value stories are underpinned by an understanding of local needs and relatable evidence.  Sue is passionate about driving cross-functional working and believes to do market access work well you have to integrate your best thinking early and collaborate without silos,  from emerging brands through to launch!!